Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy
Status:
Terminated
Trial end date:
2012-10-29
Target enrollment:
Participant gender:
Summary
Monotherapy treatment with CS-7017 to assess progression-free-survival (PFS) of subjects who
achieved an objective response of Disease Control on first line therapy with Folinic acid
(leucovorin), Fluorouracil (5-FU), Oxaliplatin (Eloxatin) known as FOLFOX; or Folinic acid
(leucovorin), Fluorouracil (5-FU), irinotecan (Camptosar) known as FOLFIRI.